What the research shows
Ten healthy men took part in a randomized, single-blind crossover study comparing oral GHRP-6 with placebo and an intravenous preparation. The researchers repeatedly measured growth hormone in blood for four hours after each exposure. The highest oral condition and the intravenous condition produced higher responses than placebo. The endpoint was a short-term hormone response in this small group. Crossover study of oral and intravenous GHRP-6.
Documented formats
The paper identifies the synthetic peptide by its six-residue sequence and describes separate oral and intravenous preparations. Exposure conditions belong with the result when comparing reports.
Testing and purity
Verify the sequence, the D-tryptophan and D-phenylalanine positions, and the amidated end group against the original methods. A report labeled only “GHRP” could describe another peptide.
How to read a batch reportQuestions about GHRP-6
Why collect multiple blood samples?
Growth hormone is released in pulses. Repeated measurements can capture the peak and the total response over time.
Did the experiment measure changes in muscle or body composition?
It measured hormone concentrations over hours. Longer-term changes in body tissues would require different measurements and follow-up.